Target Name: ZNF212
NCBI ID: G7988
Review Report on ZNF212 Target / Biomarker Content of Review Report on ZNF212 Target / Biomarker
ZNF212
Other Name(s): ZNFC150 | C2H2-150 | Zinc finger protein C2H2-150 | Zinc finger protein 212 | ZNF182 | ZN212_HUMAN | zinc finger protein 212

ZNF212: A Protein Involved in Cell Signaling and Longevity

ZNF212 (ZNFC150) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the ZNF2 gene family, which is known for its role in regulating gene expression and cell function. ZNF212 has been shown to play a role in a variety of physiological processes, including cell signaling, survival, and inflammation.

One of the unique features of ZNF212 is its ability to interact with other proteins and molecules. It has been shown to form complex with a variety of proteins, including the transcription factor ASXL1 and the protein kinase PAK3. These interactions may have important implications for the function of ZNF212 and its role in various biological processes.

In addition to its role in cell signaling and interactions, ZNF212 has also been shown to be involved in the regulation of cellular processes that are important for overall health and longevity. For example, studies have shown that ZNF212 plays a role in the regulation of cellular senescence, which is the process by which cells become less functional and eventually die. This may have implications for the development of age-related diseases such as cancer and cardiovascular disease.

Another area of research surrounding ZNF212 is its potential as a drug target. The ZNF212 protein has been shown to play a role in a variety of cellular processes that are important for overall health and disease. This makes it an attractive target for researchers and pharmaceutical companies looking for new treatments for a variety of diseases.

One potential mechanism by which ZNF212 may be targeted as a drug is its role in cell signaling. As mentioned earlier, ZNF212 has been shown to form complex with the transcription factor ASXL1 and the protein kinase PAK3. These proteins are involved in the regulation of cellular processes that are important for cell signaling and growth. By targeting these proteins, a drug that inhibits their activity could potentially be used to treat a variety of diseases.

Another potential mechanism by which ZNF212 may be targeted as a drug is its role in the regulation of cellular processes that are important for overall health and longevity. As mentioned earlier, ZNF212 has been shown to play a role in the regulation of cellular senescence. By targeting this process, a drug that inhibits its activity could potentially be used to treat a variety of age-related diseases such as cancer and cardiovascular disease.

In conclusion, ZNF212 is a protein that has been shown to play a role in a variety of physiological processes in the body. Its unique ability to interact with other proteins and molecules makes it an attractive target for researchers and pharmaceutical companies looking for new treatments for a variety of diseases. Additionally, its role in the regulation of cellular processes that are important for overall health and longevity makes it an attractive target for drugs that aim to treat age-related diseases. Further research is needed to fully understand the role of ZNF212 in these processes and to develop effective treatments.

Protein Name: Zinc Finger Protein 212

Functions: May be involved in transcriptional regulation

The "ZNF212 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF212 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1